Cardiovascular Effects of a Single Slow Release Lanreotide Injection in Patients with Acromegaly and Left Ventricular Hypertrophy

@article{Manelli1999CardiovascularEO,
  title={Cardiovascular Effects of a Single Slow Release Lanreotide Injection in Patients with Acromegaly and Left Ventricular Hypertrophy},
  author={Filippo Manelli and P. Desenzani and Enrico Boni and Giovanna Bugari and Fernanda Negrini and Giuseppe Romanelli and Vittorio Grassi and Andrea Giustina},
  journal={Pituitary},
  year={1999},
  volume={2},
  pages={205-210}
}
In our study we assessed the effects of a single i.m. injection of slow-release Lanreotide (30 mg) (SR-L), a new long-acting somatostain analog, on circulating GH levels, baseline cardiac function (M-mode, 2D guided, doppler-echocardiographic study) and cardiopulmonary response to exercise (cycloergometric test, performed using a computer drived, electrically braked cycle ergometer), tested at baseline, after 7 and 14 days from the injection in 10 acromegalic patients (5 M, 5 F, mean age 57.7… CONTINUE READING
12 Citations
29 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Symphathetic activity in acromegaly. Effect of acute octretide administration

  • R Menozzi, G Del Rio, +5 authors P. Maramma
  • J Endocrinol Invest 1997;20(Suppl
  • 1997
1 Excerpt

Similar Papers

Loading similar papers…